Leveraged buyouts have a chequered history but JPMorgan – which acted in the mega-deals of Refinitiv and AkzoNobel Specialty Chemicals – argues that both were reasonably structured and the market is different from a decade ago. Edward Russell-Walling reports.

Citi's head of EMEA investment banking, Phil Drury, talks to Kat Van Hoof about the new EMEA banking, capital markets and advisory unit and its plans to rank first for share of wallet.

When France's MedinCell needed funding to progress with the launch of a newly developed drug, it decided the time was right for a long-planned IPO. David Wigan reports.

Cross-border M&A has always been long-winded, costly and risky, but several deals that closed in 2018 stretched beyond reasonably foreseeable timescales. What is making these mergers more painful? Kat Van Hoof investigates the mechanics of antitrust in mega-mergers and the rise of protectionism.

Environmental, social and governance-focused investing has ballooned in recent years as companies realise ignoring social impact carries both financial and reputational risk. Not only that, but accessible products, such as exchange-traded funds, make the sustainable route increasingly appealing. Adrienne Klasa reports.

Credit Suisse's heads of investment banking and capital markets are leveraging their private banking network and global connectivity to ramp up growth. 

Market researcher Ipsos made its markets debut with a €300m issue, funding the acquisition of a stake in one of its rivals. David Wigan reports.

Faced with the rising tide of data resulting from increased automation, the derivatives industry is hoping technology can also play a part in helping it handle this increased burden. Jason Mitchell reports.

Europe’s burgeoning reputation for fintech and open-source software is attracting the attention of US investors. This is where Jefferies comes in, as Edward Russell-Walling reports.